Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Recombinant human diamine oxidase

EU orphan designation number: EU/3/14/1320   
Active ingredient: Recombinant human diamine oxidase
Indication: Treatment of mastocytosis
Sponsor: Medical University of Vienna
Department of Clinical Pharmacology, Währingergürtel 18-20, 1090 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/08/2014 Orphan designation EMA/OD/075/14 (2014)6126 of 22/08/2014